The online version of this article (https://doi.org/10.1007/s40200-018-0372-4) contains supplementary material, which is available to authorized users.
Diabetic foot is a complication of long-lasting diabetes mellitus affecting up to 15% of patients, both in type 1 and type 2 diabetes. Osteoprotegerin is involved in osteogenesis and calcification. The aim of the study was to assess the role of selected osteoprotegerin gene variants in diabetes patients with diabetic foot.
The study involved 300 patients with diabetes and diabetic foot and 968 healthy controls. The study group was formed by 243 patients with diabetic foot of neuropathic origin, 102 with diabetic foot of neuroischemic origin and 77 with Charcot neuroarthropathy.
Compared to controls, rs1872426 and rs1485286 showed correlation with diabetic foot in diabetes subjects. Significant associations between rs2073618, rs1872426, rs7464496 and rs1485286 in men were reported. The aforementioned correlations were also present in type 2 diabetes patient subgroup. Variant rs1485286 was associated to diabetic foot of neuropathic origin. Sex-specificity for females was present for rs6993813 in patients with diabetic foot of neuropathic origin and type 1 diabetes. Variants rs1872426, rs2073617 and rs1485286 were correlated with CN. We found that age, body weight, body mass index, waist circumference, hip circumference and waist-hip ratio were among the basic risk factors of diabetic foot.
The following variants TNFRSF11B (rs2073618, rs2073617, rs1872426, rs1032128, rs7464496, rs11573829 and rs1485286), COLEC10 (rs6993813, rs3134069) and TNFSF11 (rs9533156) present differences in allele frequencies in diabetic foot patients and show correlation with gender, diabetes type and diabetic foot etiology.
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten
ESM 1 (DOC 32 kb)40200_2018_372_MOESM1_ESM.doc
Łopatyński J, Mardarowicz G, Nicer T, Szcześniak G, Król H, Matej A, et al. The prevalence of type II diabetes mellitus in rural urban population over 35 years of age in Lublin region (eastern Poland). Pol Arch Med Wewn. 2001;106:781–6. PubMed
Abouaesha F, van Schie CH, Griffths GD, et al. Plantar tissue thickness is related to peak plantar pressure in the high-risk diabetic foot. Diabetes Care. 2001;24:1270–4. CrossRef
Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis dagger. Ann Med. 2017;49:106–16. CrossRef
Rajbhandari SM, Jenkins RC, Davies C, Tesfaye S. Charcot neuroarthropathy in diabetes mellitus. Diabetologia. 2002;45:1085–96. CrossRef
Fabrin J, Larsen K, Holstein PE. Long-term follow-up in diabetic Charcot feet with spontaneous onset. Diabetes Care. 2000;23:796–800. CrossRef
Khosla S. Minireview: the OPG/RANKL/RANK system. Endocrinology. 2001;142:5050–5. CrossRef
Hofbauer LC, Heufelder AE. Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology. J Mol Med (Berl). 2001;79:243–53. CrossRef
Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Lüthy R, et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997;89:309–19. CrossRef
Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998;93:165–76. CrossRef
Zdzisinska B, Kandefer-Szerszen M. The role of RANK/RANKL and OPG in multiple myeloma. Postepy Hig Med Dosw (Online). 2006;60:471–82.
Molines L, Darmon P, Raccah D. Charcot's foot: newest findings on its pathophysiology, diagnosis and treatment. Diabetes Metab. 2010;36:251–5. CrossRef
Pitocco D, Zelano G, Gioffrè G, et al. Association between osteoprotegerin G1181C and T245G polymorphisms and diabetic Charcot neuroarthropathy: a case-control study. Diabetes Care. 2009;32:1694–7. CrossRef
Nehring P, Mrozikiewicz-Rakowska B, Sobczyk-Kopciol A, et al. Osteoprotegerin gene rs2073617 and rs3134069 polymorphisms in type 2 diabetes patients and sex-specific rs2073618 polymorphism as a risk factor for diabetic foot. Pol Arch Med Wewn. 2013;123:176–82. PubMed
Polakowska M, Piotrowski W. Incidence of diabetes in the polish population: results of the multicenter polish population health status study--WOBASZ. Pol Arch Med Wewn. 2011;121:156–63. PubMed
Hussain SK, Al-Karawi IN, Sahab KS. Role of Fas/Fas ligand pathway in a sample of Iraq diabetic foot patients. Diyala Journal of Medicine. 2013;5:95–107.
Guldiken S, Taskiran B, Demir AM, et al. Role of soluble Fas/Fas ligand pathway and Osteoprotegerin in diabetic foot ulceration. ORTADOĞU TIP DERGİSİ. 2013;5:204–9.
Lajer M, Jorsal A, Tarnow L. Role of osteoprotegerin (OPG) in predicting development of foot ulcer and loss of foot pulse in type 1 diabetic patients with and without diabetic nephropathy. Diabetologia. 2010;53:55–6.
Korzon-Burakowska A, Jakobkiewicz-Banecka J, Fiedosiuk A, et al. Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy. Diabet Med. 2012;29:771–5. CrossRef
Jeffcoate WJ, Rasmussen LM, Hofbauer LC, Game FL. Medial arterial calcification in diabetes and its relationship to neuropathy. Diabetologia. 2009;52:2478–88. CrossRef
Mrozikiewicz-Rakowska B, Maroszek P, Nehring P, Sobczyk-Kopciol A, Krzyzewska M, Kaszuba AM, et al. Genetic and environmental predictors of chronic kidney disease in patients with type 2 diabetes and diabetic foot ulcer: a pilot study. J Physiol Pharmacol. 2015;66:751–61. PubMed
Mrozikiewicz-Rakowska B, Lukawska M, Nehring P, et al. Genetic predictors associated with diabetic retinopathy in diabetic foot patients. Pol Arch Med Wew. 2018;128:35–42.
Genre F, Lopez-Mejias R, Garcia-Bermudez M, et al. Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis. PLoS One. 2014;9:e106823. CrossRef
Veyrieras JB, Kudaravalli S, Kim SY, Dermitzakis ET, Gilad Y, Stephens M, et al. High-resolution mapping of expression-QTLs yields insight into human gene regulation. PLoS Genet. 2008;4:e1000214. CrossRef
Hulse AM, Cai JJ. Genetic variants contribute to gene expression variability in humans. Genetics. 2013;193:95–108. CrossRef
Sheng X, Cai G, Gong X, Yao Z, Zhu Y. Common variants in OPG confer risk to bone mineral density variation and osteoporosis fractures. Sci Rep. 2017;7:1739. CrossRef
Shang M, Lin L, Cui H. Association of genetic polymorphisms of RANK, RANKL and OPG with bone mineral density in Chinese peri- and postmenopausal women. Clin Biochem. 2013;46:1493–501. CrossRef
Yoshida S, Ikari K, Furuya T, Toyama Y, Taniguchi A, Yamanaka H, et al. An osteoprotegerin gene polymorphism is associated with an increased risk of hip fracture in Japanese patients with rheumatoid arthritis: results from the IORRA observational cohort study. PLoS One. 2014;9:e104587. CrossRef
Li Y, Guo Y, Wang Q, et al. Osteoprotegerin polymorphisms are associated with alcohol-induced osteonecrosis of femoral head in Chinese Han population from Henan province. J Genet. 2016;95:983–9. CrossRef
Beyens G, Daroszewska A, de Freitas F, Fransen E, Vanhoenacker F, Verbruggen L, et al. Identification of sex-specific associations between polymorphisms of the osteoprotegerin gene, TNFRSF11B, and Paget's disease of bone. J Bone Miner Res. 2007;22:1062–71. CrossRef
Dong SS, Liu XG, Chen Y, Guo Y, Wang L, Zhao J, et al. Association analyses of RANKL/RANK/OPG gene polymorphisms with femoral neck compression strength index variation in Caucasians. Calcif Tissue Int. 2009;85:104–12. CrossRef
Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet. 2010;42:1118–25. CrossRef
Biscetti F, Giovannini S, Straface G, Bertucci F, Angelini F, Porreca C, et al. RANK/RANKL/OPG pathway: genetic association with history of ischemic stroke in Italian population. Eur Rev Med Pharmacol Sci. 2016;20:4574–80. PubMed
Sassi R, Sahli H, Cheour E, Sellami S, el Gaaied ABA. -643C > T RANKL gene polymorphism is associated with osteoporosis in Tunisian postmenopausal women. Climacteric. 2017;20:374–8. CrossRef
Sosenko JM, Gadia MT, Fournier AM, O'Connell MT, Aguiar MC, Skyler JS. Body stature as a risk factor for diabetic sensory neuropathy. Am J Med. 1986;80:1031–4. CrossRef
- Selected RANKL/RANK/OPG system genetic variants in diabetic foot patients
Nikita Amit Acharya
- Springer International Publishing
Journal of Diabetes & Metabolic Disorders
Elektronische ISSN: 2251-6581
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II